Rapakko et al. screened the entire coding region of the gene in 126 Finnish breast and/or ovarian cancer families (10 of which were proven to carry a BRCA1 or BRCA2 mutation), and and Lose et al. screened 46 Australian BRCA1 and BRCA2-negative breast cancer families. This evidence concerns the gene BRCA1 and ovarian cancer.